NON-SMALL CELL LUNG CANCERS
Clinical trials for NON-SMALL CELL LUNG CANCERS explained in plain language.
Never miss a new study
Get alerted when new NON-SMALL CELL LUNG CANCERS trials appear
Sign up with your email to follow new studies for NON-SMALL CELL LUNG CANCERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Promising cancer combo trial halted after just one patient
Disease control TerminatedThis early-phase trial aimed to test the safety of combining two drugs, adagrasib and olaparib, in people with advanced solid tumors that have a specific KRAS G12C mutation. The study focused on certain cancers like gynecological, breast, pancreatic, and a type of lung cancer. Ho…
Matched conditions: NON-SMALL CELL LUNG CANCERS
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 16, 2026 12:53 UTC
-
Experimental combo for rare Gene-Mutated cancers halted early
Disease control TerminatedThis study tested a new drug (PRT3789) combined with the immunotherapy pembrolizumab in people with advanced or spreading solid tumors that have a specific genetic change called SMARCA4 mutation. The goal was to see if the combination was safe and could shrink tumors. Only 6 part…
Matched conditions: NON-SMALL CELL LUNG CANCERS
Phase: PHASE2 • Sponsor: Prelude Therapeutics • Aim: Disease control
Last updated Jun 15, 2026 19:02 UTC